Aurora Cannabis Inc. (ACB) |
|
0.6929 -0.05 (-6.71%)
|
09-26 14:42 |
|
Open: |
0.7515 |
Pre. Close: |
0.7427 |
|
High:
|
0.789 |
Low:
|
0.6835 |
|
Volume:
|
17,955,302 |
Market Cap:
|
261(M) |
|
|
|
Technical analysis |
as of: 2023-09-26 2:16:41 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 1.02 One year: 1.34 |
| Support: |
Support1: 0.43 Support2: 0.36 |
| Resistance: |
Resistance1: 0.87 Resistance2: 1.14 |
| Pivot: |
0.76  |
| Moving Average: |
MA(5): 0.74  MA(20): 0.68
MA(100): 0.57 MA(250): 0.81 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 39.9 %D(3): 42.2 |
| RSI: |
RSI(14): 51.1 |
| 52-week: |
High: 1.62 Low: 0.43 |
| Average Vol(K): |
3-Month: 20,139 (K) 10-Days: 47,745 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ACB ] has closed above bottom band by 39.9%. Bollinger Bands are 239.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.82 - 0.82 |
0.82 - 0.83 |
|
Low:
|
0.71 - 0.72 |
0.72 - 0.72 |
|
Close:
|
0.73 - 0.74 |
0.74 - 0.75 |
|
Company Description |
|
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada. |
Headline News |
Tue, 26 Sep 2023
1 Green Flag and 2 Red Flags for Aurora Cannabis Stock - The Motley Fool
Mon, 25 Sep 2023
Aurora Cannabis Inc. stock falls Monday, underperforms market - MarketWatch
Mon, 25 Sep 2023
Analysts Are Bullish On This Cannabis Stock, Should You Roll With Aurora Cannabis Inc (ACB) Monday? - InvestorsObserver
Tue, 19 Sep 2023
Aurora Launches Bold New Brand Tasty's into Canadian Adult Market - PR Newswire
Tue, 19 Sep 2023
Aurora Confirms Approval of Transfer to Nasdaq Capital Market ... - PR Newswire
Mon, 11 Sep 2023
Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All ... - The Motley Fool
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
377 (M) |
| Shares Float |
376 (M) |
|
% Held by Insiders
|
0.1 (%) |
|
% Held by Institutions
|
12.4 (%) |
|
Shares Short
|
29,280 (K) |
|
Shares Short P.Month
|
30,660 (K) |
Stock Financials |
|
EPS
|
-5.02 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.29 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-81.3 |
|
Return on Assets (ttm)
|
-9.2 |
|
Return on Equity (ttm)
|
-102.7 |
|
Qtrly Rev. Growth
|
49.9 |
|
Gross Profit (p.s.)
|
0.05 |
|
Sales Per Share
|
0.59 |
|
EBITDA (p.s.)
|
-0.39 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-142 (M) |
|
Levered Free Cash Flow
|
-54 (M) |
Stock Valuations |
|
PE Ratio
|
-0.14 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.53 |
|
Price to Sales
|
1.16 |
|
Price to Cash Flow
|
-1.85 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
